What is the Real Success Rate of IVF in Hong Kong? An Objective Analysis Based on Public Data

Document Title (not H1, but visual title)

From the first consultation at a fertility center to confirming the outcome of an embryo transfer, a complete IVF cycle typically spans 4 to 6 months. Along this timeline, a patient's focus on "success rate" goes through several stages: hoping for a precise number at the initial diagnosis, wanting to calculate probabilities based on personal indicators after tests, and focusing more on embryo quality and implantation potential before transfer. Based on data from the annual reports published by the Hong Kong Council on Human Reproductive Technology (HTA), this article deconstructs the question of "the real success rate of IVF in Hong Kong" from multiple dimensions.

1. The Most Frequently Asked Question in Clinics: What Exactly is the Success Rate?

"What is the IVF success rate in Hong Kong?" is one of the most common questions asked during fertility center consultations. However, when this question is asked, it usually implies several unclarified variables: Are you asking about the clinical pregnancy rate or the live birth rate? Does it refer to a single transfer or a complete egg retrieval cycle? Depending on the statistical measure used, the numbers can differ by 10 to 15 percentage points.

From a patient's decision-making perspective, the truly valuable indicator is the "live birth rate per initiated cycle", which is the complete probability from starting ovarian stimulation to the eventual delivery of a live infant. This indicator best reflects the overall efficacy of a center or a treatment protocol.

2. Direct Answer: Reference Range Based on HTA Public Data

According to the annual reports published over the years by the Hong Kong Council on Human Reproductive Technology, the reference ranges for live birth rates per transfer cycle by age group are as follows (Note: Data is a comprehensive statistic from multiple centers; individual results vary significantly):

Important Note: The above data is a comprehensive statistic submitted to the HTA by multiple fertility centers in Hong Kong and does not refer to any specific center. The specific figures for each center may deviate due to differences in the age distribution and diagnostic composition of the patient population they treat. For example, a center that treats a higher number of patients over 40 or with very low ovarian reserve may have statistically lower success rates than a center treating mostly standard cases, which does not directly reflect differences in technical skill.

3. Age is the Most Critical Variable Affecting Success Rate

The impact of female age on IVF success rates is fundamentally due to the biological principle that the rate of oocyte chromosomal aneuploidy increases with age. The rate of chromosomally normal embryos in patients under 35 is about 50% to 60%, while in patients over 40, it drops to below 20%, and in those over 43, it falls to less than 10%.

This means that even if the morphological grading of a transferred embryo is high, the miscarriage rate after implantation increases significantly in older age groups. Therefore, "live birth rate" is a more reliable reference indicator than "clinical pregnancy rate" because it already accounts for biochemical pregnancies and early miscarriages.

4. Three Core Indicators: AMH, FSH, and Antral Follicle Count

Ovarian reserve function is another important variable, second only to age. The three most commonly used clinical indicators are:

• AMH (Anti-Müllerian Hormone): Reflects the quantity of remaining follicles in the ovaries. AMH > 2.0 ng/mL usually indicates normal reserve, 1.0～2.0 ng/mL indicates a mild decline, and < 1.0 ng/mL indicates a significant decline. AMH does not fluctuate with the menstrual cycle and can be tested at any time.
• Basal FSH (Follicle-Stimulating Hormone): Measured by a blood test on days 2～4 of the menstrual cycle. FSH < 8 IU/L suggests good reserve, 8～12 IU/L is borderline, and > 12 IU/L usually indicates reduced reserve. A drawback of FSH is its significant fluctuation within a cycle; a single result needs to be interpreted in conjunction with AMH.
• Antral Follicle Count (AFC): The total number of follicles measuring 2～10 mm in diameter in both ovaries, counted via transvaginal ultrasound. An AFC > 10 is normal, 5～10 is mildly reduced, and < 5 is significantly reduced.

These three indicators are primarily used to predict the ovarian response to stimulation medications, not to directly predict whether an embryo will implant. A high AMH does not equal good egg quality, and normal FSH does not guarantee normal chromosomes. The ultimate determinants of success remain the chromosomal euploidy of the embryo and the uterine environment.

5. Why Do Data Differ Among Fertility Centers in Hong Kong?

There are currently over 10 fertility centers in Hong Kong holding an HTA license, including public hospital assisted reproduction units and private institutions. Differences exist in the annual data submitted by each center to the HTA, primarily due to:

• Differences in patient population composition: Some centers treat a higher number of advanced-age patients, those with multiple previous failures, or complex cases, which lowers their statistical success rate. Other centers primarily treat standard cases, resulting in relatively higher data.
• Differences in embryo culture strategies: Some centers primarily perform cleavage-stage transfers, while others focus on blastocyst transfers. Clinical pregnancy rates are generally higher with blastocyst transfers, but there is a risk of having no embryos for transfer if blastocyst culture fails.
• Proportion of PGT use: Centers that routinely perform PGT-A often transfer euploid embryos, potentially leading to higher implantation rates per transfer, but this must be weighed against the attrition caused by biopsy and freezing.

Therefore, directly comparing "success rate" numbers between different centers is of limited value. It is more worthwhile to focus on a center's ability to provide individualized management for specific patient groups (e.g., women over 38, poor ovarian responders, those with recurrent implantation failure).

6. The Most Easily Overlooked Detail: Statistical Measures and the Definition of "Success"

When patients look at data, the most easily overlooked aspect is "what is the denominator." The same "success rate" can refer to completely different indicators in different contexts:

If a center announces a "pregnancy rate" of 50%, but it refers to the clinical pregnancy rate rather than the live birth rate, and uses the per-transfer cycle as the denominator, then the actual live birth rate per initiated cycle might only be around 30%. Patients should ask the center to provide data on the "live birth rate per initiated cycle" and inquire about the age range of the patients to which this data corresponds.

7. The Easiest Pitfall: Directly Applying Group Data to Yourself

There is a lot of fragmented information online about IVF success rates in Hong Kong, some from agency promotions and some from patient testimonials. A common misconception is: seeing a center announce a "40% success rate" and assuming one's own chances are also 40%.

A success rate is essentially a group statistical result; it describes the average outcome for "a group of people with certain characteristics." An individual's actual probability depends on multiple variables including their own ovarian reserve, age, uterine environment, embryo chromosomal normality rate, and previous obstetric history. A 32-year-old patient with an AMH of 3.0 and no pelvic pathology might have a live birth rate close to 45%, whereas a 42-year-old patient with an AMH of 0.6 and a history of myomectomy might have a live birth rate of less than 10%.

The correct approach is: After completing a comprehensive fertility assessment, have your reproductive doctor provide a probability reference based on data from a similar patient population, rather than directly applying the overall number from a specific center.

8. The Doctor's Perspective: Success Rate is a Reference, Not the Sole Basis for Decision-Making

From a reproductive medicine standpoint, the success rate is an important indicator for evaluating medical quality, but it should not be the only criterion for choosing a center. The following factors are equally critical in actual decision-making:

• Laboratory Quality Control: A stable culture environment, operational standards, and a quality control system reflect long-term performance better than a "high success rate" for a single month.
• Individualized Protocol Design: Among advanced-age patients, some are suitable for mild stimulation, some for natural cycles, and others for luteal phase stimulation. The match of the protocol directly affects the number of eggs retrieved and embryo quality.
• Multidisciplinary Collaboration Capability: For complex situations involving genetic counseling, hysteroscopic surgery, or endocrine adjustments, the team's collaborative experience is more valuable than a single success rate figure.
• Transparency and Communication: Centers willing to publish detailed data (including age stratification and attrition rates at each stage) are usually more confident in their own quality.